Calendar Orphazyme A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 04:17:45 29/04/2024 pm IST			5-day change	1st Jan Change
1,090 ^DKK	0.00%		+8.46%	-18.05%

27/03	Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04/03	FDA Extends Review of Zevra's Arimoclomol by Three Months	DJ

c9536d7ca958.K7duBKYNBI0hnqH04C1uF6FI5y2yxot8f66JmW73Oec.YIMdQJ5gW-Jj99WErRskdfYNj0HLvsUXF-b_qQKOdtJ-0AU24Es10hStwg~3c686b5568577658cbd9f7555e58c1c3

27/08/2024	Q2 2024 Earnings Release (Projected)
28/02/2025	Q4 2024 Earnings Release (Projected)
02/09/2025	Q2 2025 Earnings Release (Projected)

12/09/2023	Q2 2023 Earnings Release
17/05/2023 02:30 pm	Annual General Meeting
26/04/2023 01:50 am	Q4 2022 Earnings Release
20/09/2022	Interim 2022 Earnings Release
29/06/2022 05:30 pm	Annual General Meeting
08/06/2022 03:04 am	FY 2021 Earnings Release
30/05/2022 04:30 pm	Shareholders Meeting
07/04/2022 02:30 pm	Shareholders Meeting
15/02/2022 09:30 pm	Extraordinary Shareholders Meeting
10/02/2022	WORLD Symposium - Poster 236
09/02/2022	WORLD Symposium - Poster 229
31/08/2021 05:30 pm	Interim 2021 Earnings Call
31/08/2021 10:30 am	Interim 2021 Earnings Release
18/06/2021 05:30 pm	Niemann-Pick Disease Type C (NPC) FDA Approval Update Call - Second Call
18/06/2021 11:30 am	Niemann-Pick Disease Type C (NPC) FDA Approval Update Call - First Call
12/05/2021	European Network to Cure ALS Virtual Meeting
29/04/2021 08:30 pm	B. Riley Neurosciences Conference
28/04/2021 01:45 pm	Redeye Orphan Drugs Conference
01/04/2021	Guggenheim Healthcare Talks, Genomic Medicines & Rare Diseases Conference
25/03/2021 09:30 pm	Annual General Meeting

Fiscal Period	December	2019	2020
Net sales Million DKK	Released Forecast Spread	0,00 0,00 -	0,00 1,91 -
EBITDA Million DKK	Released Forecast Spread	-332 -333 0.1%	-603 -541 -11.44%
EBIT Million DKK	Released Forecast Spread	-336 -335 -0.28%	-609 -567 -7.27%
Earnings before Tax (EBT) Million DKK	Released Forecast Spread	-343 -339 -1.33%	-635 -477 -33.13%
Net income Million DKK	Released Forecast Spread	-337 -336 -0.45%	-633 -498 -27.12%
EPS DKK	Released Forecast Spread	-16 870 -15 115 -11.61%	-22 320 -12 893 -73.12%
Announcement Date		28/02/20	02/03/21

Fiscal Period	December	2019 S2	2020 S2	2021 S1
Net sales Million DKK	Released Forecast Spread	0,00	0,00 0,00 -	13,2 0,00 -
EBITDA Million DKK	Released Forecast Spread	-171 -333 48.58%
EBIT Million DKK	Released Forecast Spread	-171 -335 48.99%	-363 -400 9.16%
Earnings before Tax (EBT) Million DKK	Released Forecast Spread		-382 -400 4.46%
Net income Million DKK	Released Forecast Spread	-174 -338 48.64%	-382 -400 4.45%
EPS DKK	Released Forecast Spread	-8 660 0,00 -
Announcement Date		28/02/20	02/03/21	31/08/21

30/04/2024	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
30/04/2024	ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
30/04/2024	WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
01/05/2024 01:35 am	EXELIXIS, INC.: Q1 2024 Earnings Release
01/05/2024	SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
01/05/2024	MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024	REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
01/05/2024	DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 04:30 pm	NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release

Today	HITGEN INC.: Q1 2024 Earnings Release (Projected)
Today	CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
26/04/2024	INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
26/04/2024	SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
26/04/2024	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
26/04/2024	REMEGEN CO., LTD.: Q1 2024 Earnings Release
26/04/2024 01:35 am	PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 04:00 pm	SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release